Luoda has developed a mastitis challenge model of Streptococcus uberis, one of the most common causes of mastitis worldwide, with the goal of assessing the safety, efficacy and milk withholding period of a novel intramammary product. Luoda has already tested one of its lead compounds against Streptococcus uberis in cattle and has demonstrated effectiveness equivalent to a leading commercial product currently available. A challenge model of Staphylococcus aureus mastitis has also been developed.
Bovine mastitis is most commonly caused by bacterial infection of the cow’s udder which reduces milk production and is potentially fatal.
|Development Status:||Clinical Development Ongoing|
|Licence Status:||First stage funding obtained|
|Commercialisation Date:||Estimated 2020|